Repithel: removing the barriers to wound healing

Area of Science:

• Wound healing research
• Biomedical engineering
• Clinical practice

Background:

• Standardized models for testing wound healing products exist but their clinical utility varies.
• High variability in wound healing necessitates better product assessment despite extensive testing.

Purpose of the Study:

• To compare preclinical testing results with clinical observations of a liposomal hydrogel containing 3% povidone-iodine (PVP-ILH).
• To evaluate the expressiveness of preclinical models and guide practitioners in using PVP-ILH.

Main Methods:

• Physicochemical testing of PVP-ILH according to ISO norms.
• In vitro and in vivo model testing of PVP-ILH.
• Comparison of laboratory results with clinical data from randomized controlled trials and case studies.

Main Results:

• PVP-ILH demonstrated good local tolerance, suitable for sensitive tissues.
• Laboratory and clinical findings confirmed PVP-ILH's ability to maintain wound moisture and manage exudates.
• Clinical results indicated effective wound debridement, attributed to the carbomer hydrogel component.

Conclusions:

• PVP-ILH effectively addresses key barriers to wound healing, including tissue management and moisture balance.
• The study supports the wound bed preparation concept (TIME) by enhancing understanding of tissue, moisture, infection, and edge management.
• Standardization of testing is crucial for comparable and understandable results in wound healing product evaluation.